Sam Possemiers

Company: MRM Health

Job title: Chief Executive Officer

Seminars:

Learnings from Clinical Development with MH002 in IBD and Translation to LBP Development for Parkinson’s Disease 1:30 pm

Reviewing Phase 2 clinical data of MH002, a next-generation microbiome therapy utilizing MRM Health’s CORAL® Technology, combining six commensal strains for targeted action in Ulcerative Colitis (UC) and Pouchitis Lessons learned and highlights on its ability to restore gut microbiome balance and improve clinical outcomes Translation of knowhow from clinical program to develop LBPs for…Read more

day: Conference Day Two, Track Two, PM